Literature DB >> 14741402

Ethanol withdrawal-induced up-regulation of the alpha2 subunit of the GABAA receptor and its prevention by diazepam or gamma-hydroxybutyric acid.

Paolo Follesa1, Francesca Biggio, Luisa Mancuso, Stefano Cabras, Stefania Caria, Giorgio Gorini, Annalisa Manca, Alessandro Orru, Giovanni Biggio.   

Abstract

The gamma-aminobutyric acid type A (GABA(A)) receptor is an important pharmacological target of ethanol. The effect of ethanol withdrawal on the expression of the alpha(2) subunit of this receptor was examined with rat cerebellar granule cells in primary culture. Long-term exposure of these cells to ethanol (100 mM, 5 days) did not affect the abundance of the mRNA for the alpha(2) subunit, as revealed by an RNase protection assay. In contrast, subsequent ethanol withdrawal for 3 h induced a marked increase in the amount of this mRNA (2.6-fold) as well as in that of the encoded polypeptide (2.2-fold), the latter revealed by immunoblot analysis. Exposure of the cells to gamma-hydroxybutyric acid (100 mM) during ethanol withdrawal prevented the increase in the amounts of both the alpha(2) mRNA and polypeptide, whereas similar treatment with diazepam (10 microM) blocked the increase in the abundance of the alpha(2) polypeptide but not that in the amount of the alpha(2) mRNA. The effect of gamma-hydroxybutyric acid was not blocked by the competitive GABA(B) receptor antagonist SCH 50911(10 microM). Given that the alpha(2) subunit of the GABA(A) receptor mediates the anxiolytic action of benzodiazepines, its up-regulation during discontinuation of long-term ethanol exposure might be relevant to the therapeutic efficacy of these drugs in the treatment of anxiety associated with ethanol withdrawal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741402     DOI: 10.1016/j.molbrainres.2003.10.011

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

Review 1.  Stress, ethanol, and neuroactive steroids.

Authors:  Giovanni Biggio; Alessandra Concas; Paolo Follesa; Enrico Sanna; Mariangela Serra
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

2.  α2 Subunit-Containing GABAA Receptor Subtypes Are Upregulated and Contribute to Alcohol-Induced Functional Plasticity in the Rat Hippocampus.

Authors:  A Kerstin Lindemeyer; Yi Shen; Ferin Yazdani; Xuesi M Shao; Igor Spigelman; Daryl L Davies; Richard W Olsen; Jing Liang
Journal:  Mol Pharmacol       Date:  2017-05-23       Impact factor: 4.436

3.  Ethanol-induced plasticity of GABAA receptors in the basolateral amygdala.

Authors:  A Kerstin Lindemeyer; Jing Liang; Vincent N Marty; Edward M Meyer; Asha Suryanarayanan; Richard W Olsen; Igor Spigelman
Journal:  Neurochem Res       Date:  2014-04-08       Impact factor: 3.996

Review 4.  Neurosteroids, GABAA receptors, and ethanol dependence.

Authors:  Paolo Follesa; Francesca Biggio; Giuseppe Talani; Luca Murru; Mariangela Serra; Enrico Sanna; Giovanni Biggio
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

5.  Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative/hypnotic tolerance.

Authors:  Indranil Bhattacharya; Joseph J Raybon; Kathleen M K Boje
Journal:  Pharm Res       Date:  2006-08-10       Impact factor: 4.200

Review 6.  The regulation of neuronal gene expression by alcohol.

Authors:  Leonardo Pignataro; Florence P Varodayan; Lindsay E Tannenholz; Neil L Harrison
Journal:  Pharmacol Ther       Date:  2009-09-23       Impact factor: 12.310

7.  Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?

Authors:  Jason B Hack; Robert S Hoffmann; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2006-06

8.  Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes.

Authors:  Michal Korostynski; Dorota Kaminska-Chowaniec; Marcin Piechota; Ryszard Przewlocki
Journal:  BMC Genomics       Date:  2006-06-13       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.